Creganna developing Micromuscle-brand biomaterial
Creganna is developing a highly engineered Micromuscle-brand biomaterial that results in change of volume in response to an electrical stimulus, typically 1-2 volts. The biomaterial can be incorporated into various medical devices.
"Functions of the advanced biocompatible electrically conductive polymers include controlled movement - swelling or contracting - and controlled release, said Alan Crean, business developer with Creganna", during a news conference in Anaheim.
"Academics at Linköping University in Linköping, Sweden, began the concept development decades ago and formed Micromuscle AB in 2000, said Magnus Krogh", Creganna new technologies representative.
Creganna, Ireland acquired Micromuscle technology and assets in October 2008, after a venture investor withdrew and forced the Linköping-based company to seek voluntary liquidation.
This site is best viewed with Internet Explorer 6.0 or higher, Firefox 2.0 or higher at a minimum screen resolution of 1024x768.
Copyright PatIntNews.Com 2007. All Right Reserved